Rapid Urine-Based Screening for Tuberculosis to Reduce AIDS-Related Mortality in Hospitalized Patients in Africa (STAMP) Trial (360G-Wellcome-105434_Z_14_Z)
Funding Organization
£395,244
Recipient Organization
Does implementation of anovel, rapid, high sensitivity urine-based screening strategy for TB used in combination with routinesputum-based standard of care diagnosis reduce all-cause mortality among HIV-infected medicalin-patients newly admitted to hospitals in southern African countries?
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 395244 |
| Applicant Surname | Fielding |
| Approval Committee | Joint Global Health Trials Committee |
| Award Date | 2014-06-03T00:00:00+00:00 |
| Financial Year | 2013/14 |
| Grant Programme: Title | Joint Global Health Trials Award |
| Internal ID | 105434/Z/14/Z |
| Lead Applicant | Prof Katherine Fielding |
| Partnership Name | Joint global health trials |
| Partnership Value | 395244 |
| Planned Dates: End Date | 2018-01-31T00:00:00+00:00 |
| Planned Dates: Start Date | 2015-02-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Greater London |